• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19:非洲悖论的机械模型支持 NF-κB 通路的核心作用。

COVID-19: Mechanistic Model of the African Paradox Supports the Central Role of the NF-κB Pathway.

机构信息

Syntacoll GmbH, 93342 Saal an der Donau, Germany.

AGES GmbH, 1200 Vienna, Austria.

出版信息

Viruses. 2021 Sep 21;13(9):1887. doi: 10.3390/v13091887.

DOI:10.3390/v13091887
PMID:34578468
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8473087/
Abstract

The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has expanded into a global pandemic, with more than 220 million affected persons and almost 4.6 million deaths by 8 September 2021. In particular, Europe and the Americas have been heavily affected by high infection and death rates. In contrast, much lower infection rates and mortality have been reported generally in Africa, particularly in the sub-Saharan region (with the exception of the Southern Africa region). There are different hypotheses for this African paradox, including less testing, the young age of the population, genetic disposition, and behavioral and epidemiological factors. In the present review, we address different immunological factors and their correlation with genetic factors, pre-existing immune status, and differences in cytokine induction patterns. We also focus on epidemiological factors, such as specific medication coverage, helminth distribution, and malaria endemics in the sub-Saharan region. An analysis combining different factors is presented that highlights the central role of the NF-κB signaling pathway in the African paradox. Importantly, insights into the interplay of different factors with the underlying immune pathological mechanisms for COVID-19 can provide a better understanding of the disease and the development of new targets for more efficient treatment strategies.

摘要

新型严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)已在全球范围内蔓延,截至 2021 年 9 月 8 日,已有超过 2.2 亿人感染,近 460 万人死亡。特别是欧洲和美洲受到高感染率和死亡率的严重影响。相比之下,非洲(撒哈拉以南地区除外)的感染率和死亡率普遍较低。对于这一非洲悖论有不同的假设,包括检测较少、人口年轻化、遗传倾向、行为和流行病学因素。在本综述中,我们讨论了不同的免疫学因素及其与遗传因素、先天免疫状态和细胞因子诱导模式的差异的相关性。我们还重点关注了流行病学因素,如特定药物的覆盖范围、撒哈拉以南地区寄生虫的分布和疟疾的流行。提出了一个综合不同因素的分析,强调了 NF-κB 信号通路在非洲悖论中的核心作用。重要的是,深入了解不同因素与 COVID-19 潜在免疫病理机制的相互作用,可以更好地理解该疾病,并为更有效的治疗策略开发新的靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c57/8473087/53d8f3dcebd6/viruses-13-01887-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c57/8473087/fd57a89d7e94/viruses-13-01887-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c57/8473087/eb42fb58329f/viruses-13-01887-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c57/8473087/02ef739b82fa/viruses-13-01887-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c57/8473087/4f7e36e64db4/viruses-13-01887-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c57/8473087/53d8f3dcebd6/viruses-13-01887-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c57/8473087/fd57a89d7e94/viruses-13-01887-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c57/8473087/eb42fb58329f/viruses-13-01887-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c57/8473087/02ef739b82fa/viruses-13-01887-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c57/8473087/4f7e36e64db4/viruses-13-01887-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c57/8473087/53d8f3dcebd6/viruses-13-01887-g005.jpg

相似文献

1
COVID-19: Mechanistic Model of the African Paradox Supports the Central Role of the NF-κB Pathway.COVID-19:非洲悖论的机械模型支持 NF-κB 通路的核心作用。
Viruses. 2021 Sep 21;13(9):1887. doi: 10.3390/v13091887.
2
Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host-environmental interactions.新型冠状病毒病 2019 与哮喘、变应性鼻炎:分子机制与宿主-环境相互作用。
Curr Opin Allergy Clin Immunol. 2021 Feb 1;21(1):1-7. doi: 10.1097/ACI.0000000000000699.
3
Coronavirus infection: An immunologists' perspective.冠状病毒感染:免疫学家的视角。
Scand J Immunol. 2021 Jun;93(6):e13043. doi: 10.1111/sji.13043. Epub 2021 Apr 7.
4
The cardiovascular disorders and prognostic cardiac biomarkers in COVID-19.COVID-19 中的心血管疾病与预后性心生物标志物。
Mol Biol Rep. 2021 Feb;48(2):1763-1771. doi: 10.1007/s11033-021-06148-9. Epub 2021 Jan 22.
5
A SARS-CoV-2 Surveillance System in Sub-Saharan Africa: Modeling Study for Persistence and Transmission to Inform Policy.撒哈拉以南非洲的新冠病毒监测系统:关于持续存在和传播以指导政策的建模研究
J Med Internet Res. 2020 Nov 19;22(11):e24248. doi: 10.2196/24248.
6
Age-Related Susceptibility of Ferrets to SARS-CoV-2 Infection.年龄相关的雪貂对 SARS-CoV-2 感染的易感性。
J Virol. 2022 Feb 9;96(3):e0145521. doi: 10.1128/JVI.01455-21. Epub 2021 Nov 24.
7
Contributions of human ACE2 and TMPRSS2 in determining host-pathogen interaction of COVID-19.人类血管紧张素转换酶2(ACE2)和跨膜丝氨酸蛋白酶2(TMPRSS2)在决定新型冠状病毒肺炎(COVID-19)宿主-病原体相互作用中的作用。
J Genet. 2021;100(1). doi: 10.1007/s12041-021-01262-w.
8
Protection against COVID-19 in African population: Immunology, genetics, and malaria clues for therapeutic targets.非洲人群对 COVID-19 的保护:免疫学、遗传学和疟疾对治疗靶点的启示。
Virus Res. 2021 Jul 2;299:198347. doi: 10.1016/j.virusres.2021.198347. Epub 2021 Feb 22.
9
SARS-CoV-2 Infection Modulates ACE2 Function and Subsequent Inflammatory Responses in Swabs and Plasma of COVID-19 Patients.SARS-CoV-2 感染可调节 COVID-19 患者拭子和血浆中的 ACE2 功能和随后的炎症反应。
Viruses. 2021 Aug 28;13(9):1715. doi: 10.3390/v13091715.
10
The Effect of COVID-19 on NF-κB and Neurological Manifestations of Disease.新型冠状病毒肺炎对 NF-κB 的影响及疾病的神经表现。
Mol Neurobiol. 2021 Aug;58(8):4178-4187. doi: 10.1007/s12035-021-02438-2. Epub 2021 Jun 1.

引用本文的文献

1
High seroprevalence of anti-SARS-CoV-2 antibodies in the capital of Chad.乍得首都抗新冠病毒抗体的高血清阳性率。
J Public Health Afr. 2023 Jan 11;13(4):2255. doi: 10.4081/jphia.2022.2255. eCollection 2022 Dec 31.
2
Special Issue "Host Targeted Therapeutics Against Virus Infections".特刊“针对病毒感染的宿主靶向治疗”
Viruses. 2024 Nov 25;16(12):1825. doi: 10.3390/v16121825.
3
COVID-19 inflammatory signature in a Mozambican cohort: unchanged red blood series and reduced levels of IL-6 and other proinflammatory cytokines.

本文引用的文献

1
SARS-CoV-2 infection induces a pro-inflammatory cytokine response through cGAS-STING and NF-κB.SARS-CoV-2 感染通过 cGAS-STING 和 NF-κB 诱导促炎细胞因子反应。
Commun Biol. 2022 Jan 12;5(1):45. doi: 10.1038/s42003-021-02983-5.
2
High seroprevalence of SARS-CoV-2 but low infection fatality ratio eight months after introduction in Nairobi, Kenya.在肯尼亚内罗毕引入八个月后,SARS-CoV-2 的血清阳性率很高,但感染病死率很低。
Int J Infect Dis. 2021 Nov;112:25-34. doi: 10.1016/j.ijid.2021.08.062. Epub 2021 Sep 2.
3
Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization.
莫桑比克队列中的 COVID-19 炎症特征:红细胞系列不变,IL-6 和其他促炎细胞因子水平降低。
BMC Infect Dis. 2024 Nov 11;24(1):1279. doi: 10.1186/s12879-024-10132-6.
4
Using mortuary and burial data to place COVID-19 in Lusaka, Zambia within a global context.利用停尸房和埋葬数据将 COVID-19 置于赞比亚卢萨卡的全球背景下。
Nat Commun. 2023 Jun 29;14(1):3840. doi: 10.1038/s41467-023-39288-6.
5
Genetic Variants within SARS-CoV-2 Human Receptor Genes May Contribute to Variable Disease Outcomes in Different Ethnicities.SARS-CoV-2 人类受体基因内的遗传变异可能导致不同种族的疾病结局存在差异。
Int J Mol Sci. 2023 May 13;24(10):8711. doi: 10.3390/ijms24108711.
6
The therapeutic effect and mechanism of parthenolide in skeletal disease, cancers, and cytokine storm.小白菊内酯在骨骼疾病、癌症及细胞因子风暴中的治疗作用及机制
Front Pharmacol. 2023 Mar 9;14:1111218. doi: 10.3389/fphar.2023.1111218. eCollection 2023.
7
COVID-19 morbidity in lower versus higher income populations underscores the need to restore lost biodiversity of eukaryotic symbionts.低收入人群与高收入人群中新冠病毒感染率的差异凸显了恢复真核共生生物已丧失生物多样性的必要性。
iScience. 2023 Mar 17;26(3):106167. doi: 10.1016/j.isci.2023.106167. Epub 2023 Feb 9.
8
Main modulators of COVID-19 epidemic in sub-Saharan Africa.撒哈拉以南非洲地区新冠疫情的主要调节因素。
Heliyon. 2023 Jan;9(1):e12727. doi: 10.1016/j.heliyon.2022.e12727. Epub 2022 Dec 29.
9
Frequency distribution of cytokine and associated transcription factor single nucleotide polymorphisms in Zimbabweans: Impact on schistosome infection and cytokine levels.津巴布韦人细胞因子和相关转录因子单核苷酸多态性的频率分布:对血吸虫感染和细胞因子水平的影响。
PLoS Negl Trop Dis. 2022 Jun 27;16(6):e0010536. doi: 10.1371/journal.pntd.0010536. eCollection 2022 Jun.
10
p53/NF-kB Balance in SARS-CoV-2 Infection: From OMICs, Genomics and Pharmacogenomics Insights to Tailored Therapeutic Perspectives (COVIDomics).SARS-CoV-2感染中的p53/NF-κB平衡:从组学、基因组学和药物基因组学见解到定制治疗前景(新冠组学)
Front Pharmacol. 2022 May 27;13:871583. doi: 10.3389/fphar.2022.871583. eCollection 2022.
德尔塔变异株对抗体中和的敏感性降低。
Nature. 2021 Aug;596(7871):276-280. doi: 10.1038/s41586-021-03777-9. Epub 2021 Jul 8.
4
Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England.评估 SARS-CoV-2 谱系 B.1.1.7 在英国的传播能力。
Nature. 2021 May;593(7858):266-269. doi: 10.1038/s41586-021-03470-x. Epub 2021 Mar 25.
5
Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant.科维希尔德腺病毒载体新冠疫苗(ChAdOx1 nCoV-19)对 B.1.351 变异株的有效性。
N Engl J Med. 2021 May 20;384(20):1885-1898. doi: 10.1056/NEJMoa2102214. Epub 2021 Mar 16.
6
Body Mass Index and Risk for COVID-19-Related Hospitalization, Intensive Care Unit Admission, Invasive Mechanical Ventilation, and Death - United States, March-December 2020.体重指数与 2020 年 3 月至 12 月期间 COVID-19 相关住院、重症监护病房收治、有创机械通气和死亡风险的关系-美国。
MMWR Morb Mortal Wkly Rep. 2021 Mar 12;70(10):355-361. doi: 10.15585/mmwr.mm7010e4.
7
Detection of a SARS-CoV-2 variant of concern in South Africa.南非出现一种令人关注的 SARS-CoV-2 变异株。
Nature. 2021 Apr;592(7854):438-443. doi: 10.1038/s41586-021-03402-9. Epub 2021 Mar 9.
8
Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19: A Randomized Clinical Trial.伊维菌素对轻症 COVID-19 成人症状缓解时间的影响:一项随机临床试验。
JAMA. 2021 Apr 13;325(14):1426-1435. doi: 10.1001/jama.2021.3071.
9
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England.在英格兰,估计 SARS-CoV-2 谱系 B.1.1.7 的传染性和影响。
Science. 2021 Apr 9;372(6538). doi: 10.1126/science.abg3055. Epub 2021 Mar 3.
10
SARS-CoV-2 variants and ending the COVID-19 pandemic.严重急性呼吸综合征冠状病毒2变体与终结2019冠状病毒病大流行
Lancet. 2021 Mar 13;397(10278):952-954. doi: 10.1016/S0140-6736(21)00370-6. Epub 2021 Feb 11.